he team that cloned the famous Dolly the sheep, abandoned his license to attempt human cloning, stating that researchers 'may have achieved what no politician could: an end to the embryonic stem cell debate.'"
"And end it we must," Margolis added, "before billions more dollars are wasted while millions of patients are forced to sit on Death Row, waiting for 21st century alchemy to magically transform embryonic stem cells into repair stem cells."
In closing, Margolis quoted Dr. Colin McGuckin, a noted UK embryonic research leader at Newcastle U. before departing for more useful RSC research in France: "The best estimates of the embryonic scientists here at Newcastle is that embryonic stem cells may not be able to help people this side of 50 years. That's my lifetime. We can't wait that long.'"
Mr. Margolis agrees: "The real cost of embryonic research is not the wasted billions, but 50 more years of unnecessary suffering by those who can be helped today."
About The Repair Stem Cell Institute: The Repair Stem Cell Institute's mission is to educate and inform everyone about the rapid advances being made in Repair Stem Cell research, so all can intelligently exercise freedom of choice in medical care. If you, or a loved one, are seeking treatment for your "untreatable" medical condition, visit http://www.repairstemcells.org for our list of the eight most experienced and successful stem cell treatment centers in the world, as well as the standards we apply to them.
###
Read the full story at http://www.prweb.com/releases/2009/03/prweb2276914.htm.
'/>"/>Source: PRWeb Copyright©2009 Vocus, Inc. All rights reserved | |
Page: 1 2 3 Related biology technology :1.
Repair Stem Cell Institute Weighs in on Reversal of Embryonic Stem Cell Policy2.
GYNECARE PROLIFT+M(TM) Pelvic Floor Repair System Launched in US for Use in Pelvic Organ Prolapse Surgery3.
Biomerix Corporation Announces FDA Clearance and Market Launch of REVIVE(TM) for Use in Soft Tissue Repair Procedures4.
Serica Technologies Receives FDA 510(k) Clearance for SeriScaffold(TM) Technology for Soft Tissue Repair5.
BioSyntech Achieves Enrolment Goal for Pivotal Trial of BST-CarGel(R), its Cartilage Repair Device6.
Positive Preclinical Data on Cell Therapy for Spinal Disc Repair Presented at 23rd Annual Meeting of the North American Spine Society7.
California State Senator Shelia Kuehls Leadership in Stem Cell Debate Praised and Embryonic Stem Cell Profiteers Criticized by Repair Stem Cell Institute Spokesman8.
Stem Cell Profits Five Years Away, Says Repair Stem Cell Institute Chairman to The Wall Street Transcript9.
Repair Stem Cell Institute Announces Industrys First Standards of Excellence for Global Stem Cell Treatment Centers to Protect Patients from Less-than-Competent Therapeutics10.
Repair Stem Cell Institute Announces Science Advisory Board11.
Worldwide Center for Adult Stem Cell Education LLC Changes Name to The Repair Stem Cell Institute LLC